Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...
A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...
Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some ...
As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...
CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...
Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.
The agreement gives Chiesi exclusive rights for the development and commercialisation of ABO-101 to treat PH1.
Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different ...
Dr. Tobias Bexte will share recent advances that overcome key barriers to making NK cell therapies safe, effective and widely ...
Classical swine fever reduces productivity and harms animal welfare, but pigs have now been genetically edited to make them ...